INTECH INVESTMENT MANAGEMENT LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1086318
WEST PALM BEACH, FL
Position in NBIX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$11,371,137
+$5,630,144 QoQ
Shares Held
86,315
+113.2% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 33.231767363725886.ToString("F0")%
Shared 0.ToString("F0")%
None 66.76823263627412.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026INTECH INVESTMENT MANAGEMENT LLC holds $94,314,635 across 29 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
311,871 | $36,866,270 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
478,939 | $14,425,641 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
20,744 | $12,300,776 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
86,315 | $11,371,137 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
44,826 | $3,400,052 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
88,945 | $2,711,043 | |
| 7 | ALKS |
Alkermes plc.
|
60,967 | $2,155,793 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
38,984 | $2,015,082 |
All Filings in NBIX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,371,137 | 86,315 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $5,740,993 | 40,478 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $4,864,868 | 34,655 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,563,059 | 28,348 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $3,962,133 | 35,824 | Shares | Defined | 2025-05-20 | |
| 2024-12-31 | $16,163,510 | 118,414 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $11,820,995 | 102,595 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $9,457,652 | 68,698 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $3,335,733 | 24,186 | Shares | Sole | 2024-08-02 | |
| 2023-12-31 | $1,616,036 | 12,265 | Shares | Sole | 2024-10-18 | |
| 2023-09-30 | $1,979,212 | 17,593 | Shares | Sole | 2024-10-18 | |
| 2023-06-30 | $1,950,218 | 20,681 | Shares | Sole | 2024-10-18 | |
| 2023-03-31 | $433,525 | 4,283 | Shares | Sole | 2024-10-18 | |
| 2022-12-31 | $547,751 | 4,586 | Shares | Sole | 2024-10-18 | |
| 2022-09-30 | $454,897 | 4,283 | Shares | Sole | 2024-10-18 | |
| 2022-06-30 | $387,580 | 3,976 | Shares | Sole | 2022-08-10 | |
| No filing history on record for this holder in this stock. | ||||||